http://classactionlawtoday.com/blogs/hbsslaw_classactionlawsuitsblog/archive/2009/07/30/blowing-the-whistle-on-the-pharmaceutical-industry.aspxBy Steve Berman Healthcare reform - depending on your point of view or even your political affiliation - is either a long-overdue step to insure our nation’s health, or the first step on a slippery slope of socialized healthcare. Regardless of your viewenCommunityServer 2007.1 (Build: 20917.1142)http://classactionlawtoday.com/blogs/hbsslaw_classactionlawsuitsblog/archive/2009/07/30/blowing-the-whistle-on-the-pharmaceutical-industry.aspx#22289Sat, 14 Nov 2009 08:55:29 GMT3db8617d-111e-48e7-81fd-7d1d8dcf9770:22289Rebeca<p>It was extremely interesting for me to read that article. Thanx for it. I like such themes and anything that is connected to this matter. I definitely want to read a bit more on that blog soon.</p> <img src="http://classactionlawtoday.com/aggbug.aspx?PostID=22289" width="1" height="1">http://classactionlawtoday.com/blogs/hbsslaw_classactionlawsuitsblog/archive/2009/07/30/blowing-the-whistle-on-the-pharmaceutical-industry.aspx#11820Mon, 10 Aug 2009 04:04:18 GMT3db8617d-111e-48e7-81fd-7d1d8dcf9770:11820Dan Abshear<p>I filed a qui tam false claims act in Boston in the Spring of 2006. &nbsp;After three years of the lawsuit remining under seal, the government did not intervene. &nbsp;The evidence I presented to the DOJ was overwhelming, and in the form of internal documents of Novartis. &nbsp;It is my belief, with the pharmaceutical industry entirely, that the DOJ is reluctant to persue these cases. &nbsp;U.S. prosecutors consider their vocation a temporary gig until they get on with a large law firm that represents corporations such as big pharma. &nbsp;It is not in their best interest to intervene against an industry they may represent in the near future. &nbsp;That&#39;s why perhaps 25 percent of pharma whistleblower cases are intervened by the DOJ.</p> <img src="http://classactionlawtoday.com/aggbug.aspx?PostID=11820" width="1" height="1">